Cosmos Health (NASDAQ:COSM) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Cosmos Health (NASDAQ:COSM) announced its earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.05), FiscalAI reports. Cosmos Health had a negative net margin of 29.33% and a negative return on equity of 43.96%. The business had revenue of $17.93 million for the quarter, compared to analysts’ expectations of $21.67 million.

Cosmos Health Trading Down 10.2%

Shares of Cosmos Health stock opened at $0.26 on Friday. Cosmos Health has a 1 year low of $0.25 and a 1 year high of $1.32. The firm has a market cap of $13.36 million, a PE ratio of -0.42 and a beta of 5.00. The stock has a fifty day moving average price of $0.33 and a 200-day moving average price of $0.45. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.00 and a quick ratio of 0.85.

Institutional Investors Weigh In On Cosmos Health

Large investors have recently added to or reduced their stakes in the company. Citadel Advisors LLC increased its holdings in Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after acquiring an additional 128,776 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Cosmos Health by 260.5% in the 4th quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock worth $167,000 after acquiring an additional 241,775 shares during the last quarter. Finally, XTX Topco Ltd increased its holdings in Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after acquiring an additional 34,117 shares during the last quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.